Max Piffoux

8PUBLICATIONS
47CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsEnvironmental biogeochemistryMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 07, 2026
Carbon Footprint of Antibody-Based Drugs and Biologics Using Hybrid Life Cycle Assessment.

|Jul 19, 2025
Integrating Environmental Impact in Health Technology Assessment: An Exploratory Study.

Coline Ducrot, Julien Péron, Matthieu Delaye

|Feb 20, 2025
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial.

Max Piffoux, Alexandra Leary, Philippe Follana

|Aug 06, 2024
Metabolomic Prediction of Breast Cancer Treatment-Induced Neurologic and Metabolic Toxicities.

Max Piffoux, Jérémie Jacquemin, Mélanie Pétéra

|May 31, 2024
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort.

Pauline Corbaux, Gilles Freyer, Olivier Glehen

|Dec 20, 2021
[Therapeutic applications of extracellular vesicles].

Kelly Aubertin, Max Piffoux, Anna Sebbagh

Pageof 2

Frequent Collaborators

2 joint publications

Benoît You

1 joint publications

Ilya Yakavets

1 joint publications

Kelly Aubertin

1 joint publications

Anna Sebbagh